Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Bovine Tuberculosis TB Diagnostic Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.3.3. Industry Opportunities
3.3.4. Industry Challenges
3.4. Bovine Tuberculosis TB Diagnostic Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the Suppliers
3.4.1.2. Bargaining power of the Buyers
3.4.1.3. Threats of Substitution
3.4.1.4. Threats from New Entrants
3.4.1.5. Competitive Rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological Landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
Chapter 4. Bovine Tuberculosis TB Diagnostic Market: Test Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Bovine Tuberculosis TB Diagnostic Market: Test Movement Analysis, 2023 & 2030 (USD Million)
4.3. Serological Tests
4.3.1. Serological Tests Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4. Molecular Diagnostic Tests
4.4.1. Molecular Diagnostic Tests Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.5. Traditional Tests
4.5.1. Traditional Tests Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 5. Bovine Tuberculosis TB Diagnostic Market: Regional Estimates & Trend Analysis
5.1. Bovine Tuberculosis TB Diagnostic Market Share, By Region, 2023 & 2030, USD Million
5.2. North America
5.2.1. North America Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. U.S. Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Canada Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.3. Europe
5.3.1. Europe Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.3.2. Germany
5.3.2.1. Germany Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.3.3. U.K.
5.3.3.1. U.K. Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.3.4. France
5.3.4.1. France Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.3.5. Italy
5.3.5.1. Italy Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Spain Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4.2. Japan
5.4.2.1. Japan Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4.3. China
5.4.3.1. China Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4.4. India
5.4.4.1. India Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4.5. Australia
5.4.5.1. Australia Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4.6. South Korea
5.4.6.1. South Korea Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Brazil Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.5.3. Mexico
5.5.3.1. Mexico Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.5.4. Argentina
5.5.4.1. Argentina Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.6. Middle East and Africa
5.6.1. Middle East and Africa Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.6.2. South Africa
5.6.2.1. South Africa Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.6.3. Saudi Arabia
5.6.3.1. Saudi Arabia Bovine Tuberculosis TB Diagnostic Market Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Heat Map Analysis
6.4. Company Profiles
6.4.1. IDEXX Laboratories, Inc.
6.4.1.1. Participant’s Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Recent Developments/ Strategic Initiatives
6.4.2. PBD Biotech Ltd.
6.4.2.1. Participant’s Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Recent Developments/ Strategic Initiatives
6.4.3. Zoetis Services LLC
6.4.3.1. Participant’s Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Recent Developments/ Strategic Initiatives
6.4.4. IDvet
6.4.4.1. Participant’s Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Recent Developments/ Strategic Initiatives
6.4.5. Thermo Fisher Scientific Inc.
6.4.5.1. Participant’s Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Recent Developments/ Strategic Initiatives
6.4.6. Enfer Group
6.4.6.1. Participant’s Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Recent Developments/ Strategic Initiatives
6.4.7. AsureQuality Australia Pty Ltd.
6.4.7.1. Participant’s Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Recent Developments/ Strategic Initiatives
6.4.8. Bio-Rad Laboratories, Inc.
6.4.8.1. Participant’s Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Recent Developments/ Strategic Initiatives
6.4.9. Bionote USA Inc.
6.4.9.1. Participant’s Overview
6.4.9.2. Financial Performance
6.4.9.3. Product Benchmarking
6.4.9.4. Recent Developments/ Strategic Initiatives